REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 164 S.R.O. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers
Full name: Dr.Max 164 S.R.O. Profile Updated: July 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 164 S.R.O. is an enterprise located in Slovakia, with the main office in Kosice. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on November 29, 2018. The total number of employees is currently 10 - 19 (2025). There was a net sales revenue increase of 19.26% reported in Dr.Max 164 S.R.O.’s latest financial highlights for 2024. During that time, Dr.Max 164 S.R.O.’s total assets grew by 19.49%. The enterprise’s net profit margin increased by 0.33% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 164 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 164 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 164 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 164 S.R.O. report to view the information.
Incorporation Date:
November 29, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 164 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
19.26%
Total operating revenue
19.19%
Operating profit (EBIT)
31.1%
EBITDA
22.08%
Net Profit (Loss) for the Period
49.21%
Total Assets
19.49%
Total Equity
35.16%
Operating Profit Margin (ROS)
0.2%
Net Profit Margin
0.33%
Return on Equity (ROE)
2.45%
Debt/Equity
-1.12%
Quick Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?